Access denied. You must login to view this page.

Mold Illness in Clinical Practice: A Foundational Guide to Recognition, Testing, and Treatment Protocols

July 23, 2026

Mold-related illness is increasingly recognized as a contributor to chronic, multi-system symptoms that often evade conventional diagnosis. From fatigue and brain fog to immune dysregulation and GI complaints, patients exposed to water-damaged buildings frequently present with vague, overlapping complaints that can be misattributed or dismissed. This one-hour foundational course equips pharmacists, physicians, nurse practitioners, physician assistants, and dietitians with a practical, evidence-informed framework for identifying mold illness, ordering appropriate conventional and functional labs, and understanding the core components of treatment protocols. Clinicians will leave with actionable tools to confidently screen patients, interpret key biomarkers, and collaborate effectively on multidisciplinary mold treatment plans.

Target Audience

This activity is designed for pharmacists, physicians, nurse practitioners, physician associates/assistants, registered nurses, and registered dietitians involved in the assessment and management of patients with chronic, complex, or unexplained multisystem conditions. The activity is particularly relevant for clinicians interested in functional, integrative, and lifestyle medicine approaches to chronic inflammatory illness.

Learning Objectives

Identify the hallmark symptoms and clinical patterns suggestive of mold-related illness across multiple body systems.
Differentiate between conventional and functional laboratory assessments used in mold evaluation, including their clinical utility and limitations.
Outline the foundational components of common mold treatment protocols, including binders, antifungals, environmental remediation, and nutritional support.
Apply role-specific strategies to support patients through assessment and treatment within an interdisciplinary care model.

Course summary

Available credit:

1.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Revelar Health, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.00 contact hour(s) (which includes 0.10 hour(s) of pharmacology).
- 0.10 AANP Pharmacology Contact Hours
1.00 AAPA Category 1 CME
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
1.00 ACPE Pharmacist
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours.
1.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material, Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.00 ANCC Contact Hours
Credit being awarded: 1.00 ANCC contact hours
1.00 Attendance
Credits: 1.00
1.00 CDR

Course opens:

07/22/2026

Course expires:

09/30/2027

Event starts:

07/23/2026 - 5:00pm EDT

Event ends:

07/23/2026 - 6:00pm EDT

Cost:

$0.00

Add to calendar:

Rating:

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Reviewer(s)